Patents by Inventor Stéphane Moutard

Stéphane Moutard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amphiphilic derivatives of triazamacrocyclic compounds, products and compositions including same, and synthesis methods and uses thereof
    Patent number: 9822083
    Abstract: The invention relates to amphiphilic derivatives of a triazamacrocyclic compound, as well as to said derivatives as active molecule transporters. The invention also relates to a nanodrug including at least one amphiphilic derivative of a triazamacrocyclic compound and at least one active molecule of a protein such as an antibody, in particular for the treatment of autoimmune diseases or for the treatment of cancer.
    Type: Grant
    Filed: January 21, 2014
    Date of Patent: November 21, 2017
    Assignee: BIOCELLCHALLENGE
    Inventors: Stéphane Moutard, Vincent Delauzun, Laurent Meunier
  • AMPHIPHILIC DERIVATIVES OF TRIAZAMACROCYCLIC COMPOUNDS, PRODUCTS AND COMPOSITIONS INCLUDING SAME, AND SYNTHESIS METHODS AND USES THEREOF
    Publication number: 20170035886
    Abstract: The invention relates to amphiphilic derivatives of a triazamacrocyclic compound, as well as to said derivatives as active molecule transporters. The invention also relates to a nanodrug including at least one amphiphilic derivative of a triazamacrocyclic compound and at least one active molecule of a protein such as an antibody, in particular for the treatment of autoimmune diseases or for the treatment of cancer.
    Type: Application
    Filed: October 19, 2016
    Publication date: February 9, 2017
    Applicant: BIOCELLCHALLENGE
    Inventors: Stéphane Moutard, Vincent Delauzun, Laurent Meunier
  • AMPHIPHILIC DERIVATIVES OF TRIAZAMACROCYCLIC COMPOUNDS, PRODUCTS AND COMPOSITIONS INCLUDING SAME, AND SYNTHESIS METHODS AND USES THEREOF
    Publication number: 20150353514
    Abstract: The invention relates to amphiphilic derivatives of a triazamacrocyclic compound, as well as to said derivatives as active molecule transporters. The invention also relates to a nanodrug including at least one amphiphilic derivative of a triazamacrocyclic compound and at least one active molecule of a protein such as an antibody, in particular for the treatment of autoimmune diseases or for the treatment of cancer.
    Type: Application
    Filed: January 21, 2014
    Publication date: December 10, 2015
    Applicant: BIOCELLCHALLENGE
    Inventors: Stéphane Moutard, Vincent Delauzun, Laurent Meunier
  • Class of cationic lipids for transporting active agents into cells
    Patent number: 9107931
    Abstract: A subject of the present invention is the development of a novel family of cationic lipids and their use as vectors for in vitro, ex vivo and in 5 vivo delivery of biologically active agents.
    Type: Grant
    Filed: February 16, 2011
    Date of Patent: August 18, 2015
    Assignee: OZ BIOSCIENCES
    Inventors: Olivier Zelphati, Stéphane Moutard
  • NOVEL CLASS OF CATIONIC LIPIDS FOR TRANSPORTING ACTIVE AGENTS INTO CELLS
    Publication number: 20120015865
    Abstract: A subject of the present invention is the development of a novel family of cationic lipids and their use as vectors for in vitro, ex vivo and in 5 vivo delivery of biologically active agents.
    Type: Application
    Filed: February 16, 2011
    Publication date: January 19, 2012
    Applicant: OZ BIOSCIENCES
    Inventors: Olivier Zelphati, Stéphane Moutard
  • Amphiphilic cyclodextrin derivatives, method for preparation thereof and uses thereof
    Patent number: 7812152
    Abstract: The invention relates to cyclodextrin derivatives of formula (I): in which: R1=—NH-E-AA-(L1)p(L2)q where E=a linear or branched C1-C15 hydrocarbon-based group with, optionally, one or more hetero atoms; AA=the residue of an amino acid; L1 and L2=a C6-C24 hydrocarbon-based group with, optionally, one or more hetero atoms; p and q=0 or 1, at least one being ?0; R2=H, —CH3, isopropyl, hydroxypropyl, sulphobutyl ether; R3=H or R2, except when R2=hydroxypropyl; all the R4=—OH or R2, except when R2=hydroxypropyl, or at least one of the R4=R1; n=5, 6 or 7. The invention also relates to a process for preparing them, and to inclusion complexes and organized surfactant systems comprising them.
    Type: Grant
    Filed: October 21, 2004
    Date of Patent: October 12, 2010
    Assignee: Commissariat a l'Energie Atomique
    Inventors: Bruno Perly, Stéphane Moutard, Florence Pilard
  • Amphiphilic cyclodextrin derivatives, method for preparation thereof and uses thereof
    Publication number: 20070142324
    Abstract: The invention relates to cyclodextrin derivatives of formula (I): in which: R1?—NH-E-AA-(L1)p(L2)q where E=a linear or branched Cl-Cl5 hydrocarbon-based group with, optionally, one or more hetero atoms; AA=the residue of an amino acid; L1 and L2=a C6-C24 hydrocarbon-based group with, optionally, one or more hetero atoms; p and q=0 or 1, at least one being ?0; R2?H, —CH3, isopropyl, hydroxypropyl, sulphobutyl ether; R3?H or R2, except when R2=hydroxypropyl; all the R4?—OH or R2, except when R2=hydroxypropyl, or at least one of the R4?R1; n=5, 6 or 7. The invention also relates to a process for preparing them, and to inclusion complexes and organized surfactant systems comprising them.
    Type: Application
    Filed: October 21, 2004
    Publication date: June 21, 2007
    Applicants: Commissariat A L'Energie Atomique, Universite De Picardie Jules Verne
    Inventors: Bruno Perly, Stephane Moutard, Florence Pilard